Author

Fauziah Asnely Putri

Observed name: Fauziah A. Putri

Institution: Interactive Research and Development

Observed institutions: Interactive Research and Development, Institut de Recherche pour le Développement, Oxford University Clinical Research Unit Indonesia

ORCID: 0009-0006-9292-7787

Observed ORCID: 0009-0006-9292-7787

OpenAlex ID: A5045680109

Randomized, Open-Label Trial of Primaquine against Vivax Malaria Relapse in Indonesia

2012 · Inge Sutanto, Bagus Tjahjono, et al. · Antimicrobial Agents and Chemotherapy · 92

Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs

2023 · Ismat Lotia Farrukh, Nathalie Lachenal, et al. · Clinical Infectious Diseases · 23

Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis

2023 · Letizia Trevisi, Miguel A. Hernán, et al. · American Journal of Respiratory and Critical Care Medicine · 23

Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis

2019 · Kwonjune J Seung, Palwasha Khan, et al. · Clinical Infectious Diseases · 21

The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort

2024 · Uzma Khan, Michael Rich, et al. · Clinical Infectious Diseases · 11

Characterizing Treatment Adherence Trajectories in the endTB Multisite Cohort of Drug-Resistant Tuberculosis Patients: An Application of Group-Based Trajectory Modeling

2025 · Stephanie Law, Isabel Fulcher, et al. · Clinical Infectious Diseases · 9

Works count: 6

Citation count: 179

H-index: 6

I10-index: 5